astrazeneca olaparib gets cdsco panel nod for brca mutated her2 negative breast cancer
Published 2 years ago • 593 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
3:50
olaparib beneficial for brca-mutated her2-negative breast cancer
-
1:48
cdsco approves astrazeneca anticancer drug trastuzumab deruxtecan protocol amendment
-
1:29
cdsco panel nod to roche anti cancer drug atezolizumab for metastatic triple negative breast cancer
-
1:42
dcgi nod to astrazeneca india breast cancer drug lynparza
-
1:11
parp inhibitors: revolutionising cancer treatment
-
8:27
reevaluating a daily low-dose of aspirin: is it right for you? | oz health
-
54:01
aspirin and cancer: the emerging evidence
-
7:16
the #1 best remedy to clean plaque from your arteries
-
4:31
astrazeneca's evp on the potential of the pharma giant's new breast cancer drug
-
0:46
antibody-drug conjugates in gynecological cancers
-
0:50
pfizer breast cancer drug fails late-stage test
-
1:20
astrazeneca cancer drug prolongs survival
-
2:15
no os benefit with lurbinectedin/doxorubicin in sclc - medpage today
-
1:46
drug shows promise in treating aggressive form of breast cancer l gma
-
10:20
these foods have natural aspirin without the risk of bleeding!
-
1:45
covid-19: antiviral pill molnupiravir approved for use in singapore
-
8:51
stop taking daily baby aspirin
-
1:10
do adcs have a future in treating breast cancer?
-
2:52
new breast cancer drug study results are promising.
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
1:41
new cancer drug shrinks all tumors!?!